{
    "symbol": "ANIK",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-07 06:36:06",
    "content": " With regards to spending, as we've discussed previously, in 2022, we are investing ahead of growth in support of our longer-term growth and profitability targets with increased spending over last year on key research and development programs consistent with the product pipeline Cheryl outlined as well as on capabilities that support our commercial transformation, including increased spending in medical education, industry events that enable us to expand our brand and product portfolio awareness and system and process enhancements."
}